![](/img/cover-not-exists.png)
Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson’s disease
Yssel, Justin D., O'Neill, Eoin, Nolan, Yvonne M., Connor, Thomas J., Harkin, AndrewLanguage:
english
Journal:
Brain, Behavior, and Immunity
DOI:
10.1016/j.bbi.2018.01.004
Date:
January, 2018
File:
PDF, 3.12 MB
english, 2018